Business Description
Nuvation Bio Inc
NAICS : 541714
SIC : 2834
Description
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 250.54 | |||||
| Equity-to-Asset | 0.96 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 0 | |||||
| Beneish M-Score | 0 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.47 | |||||
| 9-Day RSI | 42.05 | |||||
| 14-Day RSI | 39.8 | |||||
| 6-1 Month Momentum % | -33.91 | |||||
| 12-1 Month Momentum % | -39.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 45.62 | |||||
| Quick Ratio | 45.62 | |||||
| Cash Ratio | 45.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -13.44 | |||||
| ROA % | -12.9 | |||||
| ROIC % | -306.45 | |||||
| ROC (Joel Greenblatt) % | -4887.68 | |||||
| ROCE % | -14.09 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.58 | |||||
| Price-to-Tangible-Book | 1.59 | |||||
| EV-to-EBIT | -12.17 | |||||
| EV-to-EBITDA | -12.19 | |||||
| Price-to-Net-Current-Asset-Value | 1.6 | |||||
| Price-to-Net-Cash | 1.61 | |||||
| Earnings Yield (Greenblatt) % | -8.21 |
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:NUVB
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0 | ||
| EPS (TTM) ($) | -0.44 | ||
| Beta | 0 | ||
| Volatility % | 58.42 | ||
| 14-Day RSI | 39.8 | ||
| 14-Day ATR ($) | 0.398953 | ||
| 20-Day SMA ($) | 5.4615 | ||
| 12-1 Month Momentum % | -39.18 | ||
| 52-Week Range ($) | 4.46 - 15.23 | ||
| Shares Outstanding (Mil) | 219.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nuvation Bio Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nuvation Bio Inc Analysis
Share your researchHeadlines
See More
No news.